|
Mutational state frequence for FV R506Q, PT G20210A, MTHFR C677T, PAI-1 4G/5G, ACE I/D genes in patients and healhty subjects (HS). |
||||||
| Gene coagulation mutations |
Homozygous Wilde-type |
Heterozygous |
Homozygous Mutated |
|||
|
|
||||||
| Patients (17) |
HS (51) |
Patients (17) |
HS (51) |
Patients (17) |
HS (51) |
|
| FV R506Q |
94% |
98% |
6% |
2% |
- |
- |
| PT G20210A |
94% |
98% |
6% |
2% |
- |
- |
| MTHFR C677T |
41% |
57% |
41% |
31% |
18% |
12% |
| PAI-1 4G/5G |
47% |
30% |
35% |
51% |
18% |
19% |
| ACE I/D |
30% |
46% |
47% |
43% |
23% |
11% |
|
FV R506Q: factor V Leiden gene polimorphism PT G20210A: prothrombin G20210A gene polymorphism MTHFR C677T: Methylenetetrahydrofolate reductase C677T gene polymorphism PAI-1 4G/5G: plasminogen activator inihibitor 1 4G\5G gene polymorphism ACE I\D: angiotensin converting enzyme insertion\deletion gene polymorphism | ||||||
De Lucia et al. Thrombosis Journal 2006 4:21 doi:10.1186/1477-9560-4-21 |
||||||